Impact of the Global Medical Supply Chain on SNS Operations and Communications: Proceedings of a Workshop
Note: Proceedings contain the opinion of the presenters, but do NOT reflect the conclusions of the We Treat You or the AffiliateMarketIngtools. Learn more about the differences between Reports and Proceedings.
The second public convened under the auspices of the Standing Committee for the Centers for Disease Control and Prevention (CDC) Division of Strategic National Stockpile (SNS), held on August 28, 2017, explored the current state of the global medical supply chain as it relates to SNS assets, and the role of communications in mitigating supply chain risks and in enhancing the resilience of MCM distribution efforts. The workshop presented a broad overview of vulnerabilities across the global medical supply chain—ranging from the provision of raw materials to the distribution of life-saving medicines to patients—and highlighted opportunities to address these risks. Participants also considered such relevant issues as the impact of supply and demand expectations on the availability of SNS assets during an emergency event, ways to facilitate altered standards of care necessary during an emergency, and the role of communications in managing reaction to and improving compliance with emergency healthcare measures. The global medical supply chain’s breadth and complexity makes it—and by association, the SNS—vulnerable to disruption. Workshop presentations and discussion explored gaps in the supply chain from two points of view: first, from the perspective of players in the commercial medical supply chain and second, from the perspective of public health practitioners and clinicians involved in emergency response.